We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
-19.62%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$2.96B
AUM Growth
-$565M
Cap. Flow
+$186M
Cap. Flow %
6.28%
Top 10 Hldgs %
56.87%
Holding
97
New
7
Increased
34
Reduced
22
Closed
6

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$63.6M
2
BITA
Bitauto Holdings Limited
BITA
+$41.4M
3
JOYY
JOYY Inc
JOYY
+$17.5M
4
QGEN icon
Qiagen
QGEN
+$16.3M
5
NOMD icon
Nomad Foods
NOMD
+$15.6M

Sector Composition

Rank Sector Weight
1 Communication Services 24.29%
2 Industrials 17.63%
3 Technology 14.05%
4 Energy 11.84%
5 Healthcare 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
51
Apple
AAPL
$4.57T
$1.79M 0.06%
45,512
-5,288
-10% -$256K
FPRX
52
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.78M 0.06%
191,237
+69,661
+57% +$829K
AGIO icon
53
Agios Pharmaceuticals
AGIO
$1.93B
$1.73M 0.06%
37,436
+7,236
+24% +$447K
JNJ icon
54
Johnson & Johnson
JNJ
$625B
$1.71M 0.06%
13,279
-19,521
-60% -$2.72M
PRTA icon
55
Prothena Corp
PRTA
$450M
$1.67M 0.06%
161,846
+26,646
+20% +$317K
LIVN icon
56
LivaNova
LIVN
$4.2B
$1.61M 0.05%
17,654
-4,028
-19% -$433K
SGMO
57
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.59M 0.05%
138,692
+85,792
+162% +$1.07M
XRAY icon
58
Dentsply Sirona
XRAY
$2.43B
$1.59M 0.05%
42,735
+19,735
+86% +$718K
RCUS icon
59
Arcus Biosciences
RCUS
$3.64B
$1.57M 0.05%
146,193
+50,352
+53% +$588K
CSCO icon
60
Cisco
CSCO
$479B
$1.55M 0.05%
35,700
LRCX icon
61
Lam Research
LRCX
$390B
$1.51M 0.05%
110,690
+25,490
+30% +$365K
NTLA icon
62
Intellia Therapeutics
NTLA
$1.67B
$1.46M 0.05%
106,941
+51,941
+94% +$965K
CCL icon
63
Carnival Corporation Ltd
CCL
$39.7B
$1.44M 0.05%
29,260
MRK icon
64
Merck
MRK
$318B
$1.44M 0.05%
19,702
WVE icon
65
Wave Life Sciences
WVE
$1.2B
$1.35M 0.05%
32,200
INFI
66
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1.34M 0.05%
1,137,647
+146,899
+15% +$264K
PVLA
67
Palvella Therapeutics
PVLA
$2.27B
$1.32M 0.04%
6,185
+3,784
+158% +$1.17M
DNTH icon
68
Dianthus Therapeutics
DNTH
$6.09B
$1.3M 0.04%
14,314
+9,708
+211% +$1.32M
BMRN icon
69
BioMarin Pharmaceuticals
BMRN
$12.4B
$1.18M 0.04%
13,820
COGT icon
70
Cogent Biosciences
COGT
$7.24B
$1.15M 0.04%
65,149
+21,224
+48% +$628K
AERI
71
DELISTED
Aerie Pharmaceuticals
AERI
$1.14M 0.04%
31,700
ASLN
72
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$1.02M 0.03%
7,112
ADI icon
73
Analog Devices
ADI
$190B
$920K 0.03%
10,720
+4,220
+65% +$365K
EBAY icon
74
eBay
EBAY
$49.8B
$862K 0.03%
30,700
RTX icon
75
RTX Corp
RTX
$301B
$852K 0.03%
12,712

Similar funds

Platinum Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, Platinum Investment Management held 97 positions worth $2.96B, down 16% from $3.53B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Platinum Investment Management deployed $186M of net new capital in Q4 2018, opening 7 new positions and adding to 34 existing holdings. Its largest new stake was GE Aerospace: 2,131,239 shares worth $77.3M.

By sector, the portfolio is most concentrated in Communication Services at 24% of assets, down from 27% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Baidu, an estimated $63.6M trimmed.

  • Platinum Investment Management's largest Q4 2018 buy was GE Aerospace: 2,131,239 shares worth $77.3M.
  • Platinum Investment Management added most to ZTO Express in Q4 2018, an estimated $55M increase.
  • Platinum Investment Management's biggest Q4 2018 reduction was Baidu, cutting an estimated $63.6M.
  • Platinum Investment Management fully exited Nomad Foods in Q4 2018, selling an estimated $15.6M.
  • Platinum Investment Management's ten largest holdings make up 57% of its $2.96B portfolio in Q4 2018.
  • Platinum Investment Management opened 7 new positions and closed 6 in Q4 2018.
  • Platinum Investment Management's portfolio value fell 16% quarter-over-quarter to $2.96B.

Based on Platinum Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.